Philip L. McCarthy, MD

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Epstein-Barr virus-positive diffuse large B-cell lymphoma→
• Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement→
• Genetic tumor of hematopoietic and lymphoid tissues→
• Acute myeloid leukemia with recurrent genetic anomaly→
• Acute mast cell leukemia→
• Epstein-Barr virus-associated malignant lymphoproliferative disorder→
• Congenital Epstein-Barr virus infection→
• Myeloid sarcoma→
• Follicular dendritic cell sarcoma→
• AL amyloidosis→
• Acquired idiopathic sideroblastic anemia→
• Diffuse lymphatic malformation→
• Graft versus host disease→
• Lymphomatoid granulomatosis→

Clinical trials (7)

• NCT00534118
• NCT00053989
• NCT00060255
• NCT00003816
• NCT00055653
• NCT00053157
• NCT00055666

Verify independently

• ClinicalTrials.gov PI search for Philip L. McCarthy, MD

Other specialists for Epstein-Barr virus-positive diffuse large B-cell lymphoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Kurt Gunter, MD, M.D
  Inozyme Pharma, Inc.
  MA
• Ajay Gopal
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
  WA
• Colleen Delaney, MD
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
  CT
• Jennifer Crombie, MD, M.D
  Dana-Farber Cancer Institute
  MA
• Nancy Wells, DNSc, RN
  Vanderbilt-Ingram Cancer Center
• Paul Martin
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
• Karen Syrjala
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
  WA
• Mary Laughlin, MD
  Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

See all specialists for Epstein-Barr virus-positive diffuse large B-cell lymphoma →